Related Experiment Video

Updated: Aug 8, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Obscured bone metastases after administration of hematopoietic factor on FDG-PET

Avneesh Chhabra1, Kiran Batra, P Todd Makler

  • 1Department of Radiology, Drexel University College of Medicine, Hahnemann University Hospital, Philadelphia, PA 19102, USA. avneesh28@yahoo.com

Clinical Nuclear Medicine
|May 23, 2006
PubMed

Insights

Intense bone marrow activity can obscure rare tumor metastases on initial FDG-PET scans. A follow-up scan revealed these hypermetabolic lesions, aiding diagnosis.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Rare tumors can present with challenging metastatic patterns.
  • Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) is crucial for staging and monitoring cancer.
  • Hematopoietic factors can increase bone marrow activity, potentially affecting FDG uptake.

Observation:

  • A patient with bony metastases from a rare tumor exhibited obscured lesions on an initial FDG-PET scan.
  • Intense bone marrow activity, secondary to hematopoietic factor administration, masked the metastatic lesions.
  • Correlative Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and histopathology provided complementary diagnostic information.

Findings:

  • The initial FDG-PET scan showed obscured metastatic lesions due to high bone marrow uptake.
  • Subsequent MRI, CT, and pathology confirmed the presence of bony metastases.
  • A follow-up FDG-PET scan successfully identified the hypermetabolic metastatic lesions.

Implications:

  • This case highlights the potential for confounding factors, such as hematopoietic factors, to affect FDG-PET imaging interpretation.
  • Awareness of these imaging challenges is critical for accurate diagnosis and staging of rare tumors.
  • Correlative imaging modalities and follow-up scans are essential when initial findings are equivocal.

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm06:53

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Published on: July 23, 2020

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...